Company profile: Chemos
1.1 - Company Overview
Company description
- Provider of ready-to-use solutions for laboratories and the chemical industry, offering raw materials for organic synthesis, active ingredients for the pharmaceutical and food industries, and various catalysts and crosslinkers; also provides manual filling lines for solid and liquid.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Chemos
Clinical Ink
HQ: United States
Website
- Description: Provider of eSource solutions for the clinical trials industry, offering software to record validated source data, comments, and explanations on protocol-specific electronic documents via mobile devices, including its SureSource electronic source solution that captures data required by trial protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Ink company profile →
PMOD Technologies
HQ: Switzerland
Website
- Description: Provider of software quantification tools for biomedical imaging in humans and animals. PMOD software originated in 1993, developed at the University Hospital PET Center in Zurich when PET was mainly a research tool, and was adopted by the PET community.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PMOD Technologies company profile →
CCT Research
HQ: United States
Website
- Description: Provider of embedded clinical trial services, conducting Phase II–IV studies in family medicine, neurology, dermatology, and vaccines by integrating research sites into physician offices. Operates a network of over 30 sites across the US with centralized staffing, data and regulatory management, patient recruitment, investigator partnerships, and site business development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CCT Research company profile →
BEKHealth
HQ: United States
Website
- Description: Provider of AI-powered chart abstraction and patient-matching solutions that analyze structured and unstructured EMR data to optimize clinical trial enrollment. Services include an automated ETL pipeline via proprietary EMR adapters, an AI data platform to standardize and translate medical data, patient matching, study rescue, and sponsor–site matching.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BEKHealth company profile →
X-Chem
HQ: United States
Website
- Description: Provider of AI-driven small molecule drug discovery solutions, including ArtemisAI to analyze DEL data and predict new binders; DEL screening services across target classes; medicinal chemistry to convert hits into leads; integrated Dynamic Drug Discovery (XD3); HITMiner to expand binder predictions; and LEADChaser to advance DEL outputs through rapid design-test loops.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X-Chem company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Chemos
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Chemos
2.2 - Growth funds investing in similar companies to Chemos
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Chemos
4.2 - Public trading comparable groups for Chemos
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →